ClinicalTrials.gov
ClinicalTrials.gov Menu

Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer (SOFIA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00548899
Recruitment Status : Completed
First Posted : October 24, 2007
Last Update Posted : March 9, 2015
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
German Breast Group